HIV/AIDS Therapy
Dextrin sulphate against HIV is well tolerated without systemic absorption
Published in AIDS Weekly, January 30th, 2006
Scientists writing in the journal Sexually Transmitted Diseases reported, "This phase I dose-ranging study of 2 weeks of twice-daily dextrin sulphate (DS), a sulphated polymer with in vitro activity against HIV, was designed in 2 parts. Part A was a randomized, placebo-controlled, double-blind, 3-arm trial (DS4%, DS1%, placebo) in HIV-negative women."
"In part B," described S. McCormack and colleagues, "HIV-positive women received DS4% and HIV-negative women were randomized to DS4% or no gel. One hundred women were enrolled from 2 sites (London and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-30)
More Articles from AIDS Weekly
- Drug Development
Indirubin-3'-monoxime inhibits P-TEFb function and HIV-1 replication - HIV/AIDS Drug Delivery
Zidovudine plasma levels increase when dosed as a prodrug in liposomal form - HIV/AIDS Drug Resistance
Drug-resistance mutations identified in HAART-naive HIV-infected patients - HIV/AIDS Vertical Transmission
Lower vertical HIV-1 transmission in boys independent of type of delivery or prophylaxis - Allergy & Immunology
Intracisternal A-type retroviral particle type I isolated from SLE patients - Avian Influenza
Diagnostics company begins work on rapid test kit for avian influenza - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
